Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125255111 | 12525511 | 1 | I | 201602 | 20160622 | 20160704 | 20160704 | PER | US-ASTRAZENECA-2016SE69314 | ASTRAZENECA | 22311.00 | DY | F | Y | 99.80000 | KG | 20160705 | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125255111 | 12525511 | 1 | PS | BYDUREON | EXENATIDE | 1 | Subcutaneous | 6 | MG | U | 22200 | 2 | MG | /wk | |||||
125255111 | 12525511 | 2 | SS | BYETTA | EXENATIDE | 1 | Subcutaneous | U | 0 | 10 | SOLUTION FOR INJECTION IN PRE-FILLED PEN | BID |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
125255111 | 12525511 | 1 | Type 2 diabetes mellitus |
125255111 | 12525511 | 2 | Type 2 diabetes mellitus |
Outcome of event
no results found |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
125255111 | 12525511 | Blood glucose decreased | |
125255111 | 12525511 | Crying | |
125255111 | 12525511 | Loss of consciousness | |
125255111 | 12525511 | Weight decreased | |
125255111 | 12525511 | Weight increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
125255111 | 12525511 | 1 | 20160201 | 20160324 | 0 | |
125255111 | 12525511 | 2 | 20160324 | 20160421 | 0 |